HOME Top Market Reports Molecular Diagnostics Market by Application (Infectious Disease, Oncology, Genetics, Microbiology), Technology (PCR, INAAT, DNA Sequencing), End User (Hospital, Laboratories), Product (Instruments, Reagent, Service, Software) - Global Forecasts to 2018

Molecular Diagnostics Market by Application (Infectious Disease, Oncology, Genetics, Microbiology), Technology (PCR, INAAT, DNA Sequencing), End User (Hospital, Laboratories), Product (Instruments, Reagent, Service, Software) - Global Forecasts to 2018

By: marketsandmarkets.com
Publishing Date: June 2014
Report Code: MD 2521

 

  Speak to Analyst Enquiry Before Buying
 
purchase report
download pdf  request for customisation


The global molecular diagnostics market is estimated to reach $7,956.9 million by 2018, at a CAGR of 9.7% during the forecast period (2013–2018). The factors driving the growth of this market include the increasing infectious diseases, rising incidences of cancer, genetic disorders, and blood screening. The factors restraining this market include the economic downturn and saturation and the unstable reimbursement regulations in developed countries.

The molecular diagnostics market is categorized on the basis of application, technology, end user, product, and geography. On the basis of application, infectious diseases were the leading market segment, in 2013. Under this segment the CT/NG sub-segment contributed to the maximum share of the market. The MRSA sub-segment will be the fastest growing segment by 2018. The major factor that drives the growth of this segment is the rise in the population size of the patients affected by the infectious diseases.

On the basis of technology, PCR was the fastest growing segment and is expected to grow further within the forecast period. This growth can be attributed to the dominant nature and acceptance of PCR over other technologies. Microarray technology is expected to drive the market at the highest CAGR in the forecast period.

On the basis of end user, hospital segment showed the highest market share. This can be attributed to the growing population that gives rise to the awareness regarding various technologies available in the molecular diagnostics market. The reference laboratory segment is expected to grow at the highest CAGR in the forecasted period.

The product segment of the molecular diagnostics market comprises of instruments, reagents, and services and software. The reagents segment accounted for the highest market share and is expected to grow at a rapid pace in the forecasted period. The instruments segment will show a moderate growth as compared to the reagents segment, in the forecasted period.

In 2013, North America accounted for the largest share in the market and is expected to grow from 2013 to 2018, at a higher CAGR than Europe. This growth can be attributed to the rise in the infectious diseases, cancer cases and the increasing incidence of lifestyle diseases. Europe accounted for the second largest market share in 2013; however, in the forecast period the growth of this region will be slow. Asia, on the other hand, will be the main focus of the market in the coming five years and will register higher growth rates for all its segments. The vast population size in countries such as India and China and the improved purchasing power of the rising middle class will drive the growth of this region.

The key players in the molecular diagnostics market are Roche Diagnostics (Switzerland), Hologic Gen-Probe (U.S.), QIAGEN (Netherlands), Becton, Dickinson & Company (U.S.), Siemens Healthcare (Germany), bioMιrieux (France), Abbott Laboratories (U.S.), Novartis AG (Switzerland), Cepheid (U.S.), and Beckman Coulter (U.S.).

Scope of the Report


Particulars

Scope

Geography

  • North America
  • Europe
  • Asia
  • RoW (Latin America, Middle East, and Africa)

Historical Years

2011–2012

Base Year

2013

Forecast Period

2014–2018

Revenue Currency

USD ($)

This research report categorizes the global molecular diagnostics market into the following segments and sub-segments:

By Application

  • Infectious Disease
    • HBV
    • HCV
    • HIV
    • TB
    • CT/NG
    • HPV
    • MRSA
    • Others
  • Oncology
    • Prostate Cancer
    • Breast Cancer
    • Colorectal Cancer
    • Others
  • Genetics
  • Blood Screening
  • Microbiology
  • Others

By Technology

  • PCR
  • INAAT
  • Hybridization
  • DNA Sequencing & NGS
  • Microarray
  • Others

By End User

  • Reference Laboratories
  • Hospitals/Academics
  • Others

By Product

  • Instruments
  • Reagents
  • Services and Software

By Geography

  • North America
  • Europe
  • Asia
  • Rest of the World

Table Of Contents
 
1 Introduction (Page No. - 17)
    1.1 Objectives of the Study
    1.2 Report Description
    1.3 Markets Covered
    1.4 Stakeholders
    1.5 Market Scope
    1.6 Research Methodology
          1.6.1 Market Size Estimation & Data Triangulation
          1.6.2 Key Data From Secondary Sources
          1.6.3 Key Data Points From Primary Sources
          1.6.4 Assumptions

2 Executive Summary (Page No. - 28)

3 Premium Insight (Page No. - 32)

4 Market Overview (Page No. - 41)
    4.1 Introduction
    4.2 Market Segmentation
    4.3 Market Dynamics
          4.3.1 Drivers
                  4.3.1.1 Increasing Awareness and Acceptance of Personalized Medicine and Companion Diagnostics
                  4.3.1.2 Development of Biomarker Identification and Advancements in Molecular Techniques
                  4.3.1.3 Proteomics and Genomics Technology Research to Goad the Molecular Testing Market
                  4.3.1.4 Increase in AGing Population to Spur Growth of the Molecular Diagnostics Market
                  4.3.1.5 Reformations in the Reimbursement System
          4.3.2 Restraints
                  4.3.2.1 Increased Costs of Molecular Diagnostics tools With New and Complex Platforms Demand Skilled Labor and Mandatory Training
                  4.3.2.2 Reimbursement Issues
                  4.3.2.3 Complex Regulatory Framework to Delay Approvals of New Molecular Diagnostic Tests
          4.3.3 Opportunities
                  4.3.3.1 Extending the Reach of Molecular Diagnostics
                  4.3.3.2 Emerging Technologies Can Soon Gain Importance in Molecular Diagnostic Tests
          4.3.4 Threats
                  4.3.4.1 Lack of Budget and Labor
                  4.3.4.2 Stringent Regulatory Framework to Stifle the Growth of Mdx Market
    4.4 Market Share Analysis
    4.5 Molecular Diagnostic Laboratories and Tests
    4.6 End-User Analysis
    4.7 Effects of Obamacare on the Molecular Diagnostics Market

5 Global Molecular Diagnostics Market, By Application (Page No. - 57)
    5.1 Introduction
    5.2 Infectious Diseases
          5.2.1 Hepatitis B Virus (HBV)
          5.2.2 Hepatitis C Virus (HCV)
          5.2.3 Human Immunodeficiency Virus (HIV)
          5.2.4 Tuberculosis (TB)
          5.2.5 Chlamydia Trachomatis and Neisseria Gonorrhea (CT/NG)
          5.2.6 Human Papillomavirus (HPV)
          5.2.7 Methicillin-Resistant Staphylococcus Aureus (MRSA)
          5.2.8 Others
    5.3 oncology
          5.3.1 Prostate Cancer
          5.3.2 Breast Cancer
          5.3.3 Colorectal Cancer
          5.3.4 Others
    5.4 Genetics
    5.5 Blood Screening
    5.6 Microbiology
    5.7 Others

6 Global Molecular Diagnostics Market, By Technology (Page No. - 76)
    6.1 Introduction
    6.2 Polymerase Chain Reaction (PCR)
    6.3 Isothermal Nucleic Acid Amplification Technology (INAAT)
    6.4 Microarrays
    6.5 Hybridization (in Situ Hybridization and Fluorescence in Situ Hybridization)
    6.6 Dna Sequencing & Next-Generation Sequencing
    6.7 Others

7 Global Molecular Diagnostics Market, By Product Type (Page No. - 89)
    7.1 Introduction
    7.2 Instruments
    7.3 Reagents
    7.4 Services & Software

8 Geographic Analysis (Page No. - 97)
    8.1 Introduction
    8.2 North America
          8.2.1 U.S.
          8.2.2 Canada
    8.3 Europe
          8.3.1 U.K.
          8.3.2 Germany
          8.3.3 France
          8.3.4 Italy
          8.3.5 Spain
          8.3.6 Rest of Europe
    8.4 Asia
          8.4.1 Japan
          8.4.2 India
          8.4.3 China
          8.4.4 Rest of Asia (ROA)
    8.5 Rest of the World (ROW)
          8.5.1 Latin America
          8.5.2 Pacific
          8.5.3 Middle East & Africa

9 Competitive Landscape (Page No. - 164)
    9.1 Introduction
    9.2 New Product Launch
    9.3 Mergers & Acquisitions
    9.4 Agreement/Partnership/Collaboration
    9.5 Expansion
    9.6 Other Developments

10 Company Profiles (Overview, Financials, Products & Services, Strategy, & Developments)* (Page No. - 203)
    10.1 Abbott Diagnostics, Inc.
    10.2 Beckman Coulter, Inc.
    10.3 Becton, Dickinson & Co.
    10.4 Biomιrieux Business Overview
    10.5 Cepheid, Inc.
    10.6 Gen-Probe, Inc. (Hologic, Inc.)
    10.7 Novartis AG
    10.8 Qiagen
    10.9 Roche Diagnostics
    10.1 Siemens Healthcare

*Details on Financials, Product & Services, Strategy, & Developments Might Not Be Captured in Case of Unlisted Companies.

List of Tables (92 Tables)

Table 1 Molecular Diagnostics Market, By Geography, 2011–2018 ($Million)
Table 2 Global Market, By Application, 2011–2018 ($Million)
Table 3 Total Number of Molecular Diagnostic Laboratories, By Region 2011-2018
Table 4 Total Number of Molecular Diagnostic Tests, By Region 2011-2018, (Millions)
Table 5 Global Molecular Diagnostics Market Size, By End User, 2011–2018 ($Million)
Table 6 Global Molecular Diagnostics Market Size, By Application, 2011–2018 ($Million)
Table 7 Global Infectious Diseases Molecular Diagnostics Market Size, By Type of Disease, 2011–2018 ($Million)
Table 8 Infectious Diseases Molecular Diagnostics Market Size, By Region, 2011–2018 ($Million)
Table 9 Global Oncology Molecular Diagnostics Market Size, By Type, 2011–2018 ($Million)
Table 10 Oncology Molecular Diagnostics Market Size, By Region, 2011–2018 ($Million)
Table 11 Genetics Molecular Diagnostics Market Size, By Region, 2011–2018 ($Million)
Table 12 Blood Screening Molecular Diagnostics Market Size, By Region, 2011–2018 ($Million)
Table 13 Microbiology Molecular Diagnostics Market Size, By Region, 2011–2018 ($Million)
Table 14 Other Molecular Diagnostics Market Size, By Region, 2011–2018 ($Million)
Table 15 Global Molecular Diagnostics Market Size, By Technology, 2011–2018 ($Million)
Table 16 PCR Technology Market Size, By Region, 2011–2018 ($Million)
Table 17 INAAT Market Size, By Region, 2011–2018 ($Million)
Table 18 Microarray Technology Market Size, By Region, 2011–2018 ($Million)
Table 19 Hybridization Technology Market Size, By Region, 2011–2018 ($Million)
Table 20 Dna Sequencing & Ngs Molecular Diagnostics Market Size, By Region, 2011–2018 ($Million)
Table 21 Other Molecular Diagnostics Technologies Market Size,By Region, 2011–2018 ($Million)
Table 22 Global Molecular Diagnostics Market Size, By Type of Product & Service, 2011–2018 ($Million)
Table 23 Molecular Diagnostics Instruments Market Size, By Region, 2011–2018 ($Million)
Table 24 Molecular Diagnostics Reagents Market Size, By Region, 2011–2018 ($Million)
Table 25 Molecular Diagnostics Services & Software Market Size, By Region, 2011–2018 ($Million)
Table 26 Molecular Diagnostics Market Size, By Geography, 2011–2018 ($Million)
Table 27 North America: Molecular Diagnostics Market Size, By Country, 2011–2018 ($Million)
Table 28 North America: Market Size, By Application, 2011–2018 ($Million)
Table 29 North America: Market Size, By Technology, 2011–2018 ($Million)
Table 30 North America: Market Size, By Type of Product & Service, 2011–2018 ($Million)
Table 31 U.S.: Molecular Diagnostics Market Size, By Application, 2011–2018 ($Million)
Table 32 U.S.: Market Size, By Technology, 2011–2018 ($Million)
Table 33 U.S.: Market Size, By Type of Product & Service, 2011–2018 ($Million)
Table 34 Canada: Market Size, By Application, 2011–2018 ($Million)
Table 35 Canada: Market Size, By Technology, 2011–2018 ($Million)
Table 36 Canada: Market Size, By Type of Product & Service, 2011–2018 ($Million)
Table 37 Europe: Market Size, By Country, 2011–2018 ($Million)
Table 38 Europe: Market Size, By Application, 2011–2018 ($Million)
Table 39 Europe: Market Size, By Technology, 2011–2018 ($Million)
Table 40 Europe: Market, By Type of Product & Service, 2011–2018 ($Million)
Table 41 U.K.: Market Size, By Application, 2011–2018 ($Million)
Table 42 U.K.: Market Size, By Technology, 2011–2018 ($Million)
Table 43 U.K.: Market Size, By Type of Product & Service, 2011–2018 ($Million)
Table 44 Germany: Market Size, By Application, 2011–2018 ($Million)
Table 45 Germany: Market Size, By Technology, 2011–2018 ($Million)
Table 46 Germany: Market, By Type of Product & Service, 2011–2018 ($Million)
Table 47 France: Market Size, By Application, 2011–2018 ($Million)
Table 48 France: Market Size, By Technology, 2011–2018 ($Million)
Table 49 France: Market Size, By Type of Product & Service, 2011–2018 ($Million)
Table 50 Italy: Market Size, By Application, 2011–2018 ($Million)
Table 51 Italy: Market Size, By Technology, 2011–2018 ($Million)
Table 52 Italy: Market Size, By Type of Product & Service, 2011–2018 ($Million)
Table 53 Spain: Market Size, By Application, 2011–2018 ($Million)
Table 54 Spain: Market Size, By Technology, 2011–2018 ($Million)
Table 55 Spain: Market Size, By Type of Product & Service, 2011–2018 ($Million)
Table 56 Rest of Europe: Market Size, By Application, 2011–2018 ($Million)
Table 57 Rest of Europe: Market Size, By Technology, 2011–2018 ($Million)
Table 58 Rest of Europe: Market Size, By Type of Product & Service, 2011–2018 ($Million)
Table 59 Asia: Market Size, By Region, 2011–2018 ($Million)
Table 60 Asia: Market Size, By Application, 2011–2018 ($Million)
Table 61 Asia: Market Size, By Technology, 2011–2018 ($Million)
Table 62 Asia: Market Size, By Type of Product & Service, 2011–2018 ($Million)
Table 63 Japan: Market Size, By Application, 2011–2018 ($Million)
Table 64 Japan: Market Size, By Technology, 2011–2018 ($Million)
Table 65 Japan: Market Size, By Product&Service Type, 2011–2018 ($Million)
Table 66 India: Market Size, By Application, 2011–2018 ($Million)
Table 67 India: Market Size, By Technology, 2011–2018 ($Million)
Table 68 India: Market Size, By Type of Product & Service, 2011–2018 ($Million)
Table 69 China: Market Size, By Application, 2011–2018 ($Million)
Table 70 China: Market Size, By Technology, 2011–2018 ($Million)
Table 71 China: Market Size, By Type of Product & Service, 2011–2018 ($Million)
Table 72 ROA: Molecular Diagnostics Market Size, By Application, 2011–2018 ($Million)
Table 73 ROA: Market Size, By Technology, 2011–2018 ($Million)
Table 74 ROA: Market Size, By Type of Product & Services, 2011–2018 ($Million)
Table 75 ROW: Market Size, By Region, 2011–2018 ($Million)
Table 76 ROW: Market Size, By Application, 2011–2018 ($Million)
Table 77 ROW: Market Size, By Technology, 2011–2018 ($Million)
Table 78 ROW: Market Size, By Type of Product & Service, 2011–2018 ($Million)
Table 79 Latin America: Market Size, By Application, 2011–2018 ($Million)
Table 80 Latin America: Market Size, By Technology, 2011–2018 ($Million)
Table 81 Latin America: Market Size, By Type of Product & Service, 2011–2018 ($Million)
Table 82 Pacific: Market Size, By Application, 2011–2018 ($Million)
Table 83 Pacific: Market Size, By Technology, 2011–2018 ($Million)
Table 84 Pacific: Market Size, By Type of Product & Service, 2011–2018 ($Million)
Table 85 Middle East & Africa: Molecular Diagnostics Market Size, By Application, 2011–2018 ($Million)
Table 86 Middle East & Africa: Market Size, By Technology, 2011–2018 ($Million)
Table 87 Middle East & Africa: Market Size, By Type of Product & Service, 2011–2018 ($Million)
Table 88 New Product Launch(2011-2014)
Table 89 Mergers & Acquisitions (2011-2014)
Table 90 Agreement/Partnership/Collaboration(2011-2014)
Table 91 Expansion(2011-2012)
Table 92 Other Developments(2011-2014)


List of Figures (18 Figures)

Figure 1 Market Size Estimation and Data Triangulation
Figure 2 Forecast Model
Figure 3 Global Molecular Diagnostics Market, By Technology, 2013–2018 ($Million)
Figure 4 Global Moleculer Diagnostics Market, 2011-2018 ($Million)
Figure 5 Market Dynamics
Figure 6 Market Snapshot, 2013 ($Million)
Figure 7 Global Market Share Analysis, By Application, 2013 & 2018
Figure 8 Opportunity Matrix, Global Market Size, By Technology, 2013
Figure 9 Global Market, By End-User, 2013 & 2018 ($Million)
Figure 10 Global Market Share Analysis, By Product 2013
Figure 11 Global Molecular Diagnostics Market
Figure 12 Global Market, Share Analysis, 2013
Figure 13 Global Market, By End User, 2013 ($Million)
Figure 14 Opportunity Matrix, Global Market, By Application, 2013
Figure 15 Global Market Share Analysis, By Technology (2013 & 2018)
Figure 16 Global Market Size, By Product, 2018 ($Million)
Figure 17 Molecular Diagnostics Market, Geographic Analysis, By Application 2013 ($Million)
Figure 18 Key Growth Strategies, Molecular Diagnostics Market, 2011–2018

The molecular diagnostics market is segmented into five major segments, namely, application, technology, end user, product, and geography.

The global molecular diagnostics market was valued as $5.01 billion in 2013 and is poised to grow at a CAGR of 9.7% by 2018. The market is driven by rise in the infectious diseases, growing incidences of unhealthy lifestyle diseases, and increasing breast cancer cases. However, the economic crisis and unpredictable reimbursement policies will restrain the growth of this market to an extent. Reagents will be one of the most fruitful segments for the companies to invest in the near future.

The applications segment is further subdivided into infectious diseases, oncology, genetics, blood screening, microbiology, and others. Infectious diseases were the leading segment in 2013 owing to the growing population.

The technology market is subdivided into PCR, INAAT, hybridization, DNA sequencing and NGS, microarray, and others. Out of these, PCR was the leading segment while microarray is expected to be the fastest growing segment during the forecast period. This growth is due to the rise in infectious and lifestyle diseases.

The end user segment is subdivided into reference laboratories, hospitals, and others. Out of these, the reference laboratory segment accounted for the highest CAGR.

The product segment is further sub-divided into instruments, reagents, and services and software. The growth will be majorly driven due to use of reagents for molecular testing of infectious diseases.

The geographic analysis reveals that North America accounted for the largest share and is expected to grow from 2013 to 2018 at a high CAGR. In 2013, Europe accounted for the second largest share in this market; however the growth of this region will be inactive in the forecast period. Asia will be the most profitable region for the molecular diagnostic devices in the coming five years. It is poised to grow at a healthy CAGR in the forecast period.

The key players in the molecular diagnostics market are Roche Diagnostics (Switzerland), Gen-Probe (Hologic) (U.S.), QIAGEN (Netherlands), Becton, Dickinson & Company (U.S.), Siemens Healthcare (Germany), bioMιrieux (France), Abbott (U.S.), Novartis AG (Switzerland), Cepheid (U.S.), and Beckman Coulter (U.S.).

Global Molecular Diagnostics Market Size Snapshot, 2013 ($Million)

Molecular Diagnostics Market

Custom Market Research Services

We will customize the research for you, in case the report listed above does not meet with your exact requirements. Our custom research will comprehensively cover the business information you require to help you arrive at strategic and profitable business decisions.

Please visit http://www.marketsandmarkets.com/knowledge-process-outsourcing-services.asp to specify your custom Research Requirement

Connect With Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441
UK : 44-800-368-9399

Search reports